VitalStone Financial’s Quest Diagnostics DGX Stock Holding History

VitalStone Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.1K	Buy	+20	New	+$2.99K	﹤0.01%	347

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

VitalStone Financial's DGX Position: Q3 2024 in Review

VitalStone Financial opened a new position in Quest Diagnostics (DGX) in Q3 2024: 20 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #347 among its holdings.

847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

VitalStone Financial held 20 shares of Quest Diagnostics worth $3.1K as of Q3 2024.
Quest Diagnostics was a new VitalStone Financial position in Q3 2024.
Quest Diagnostics made up ﹤0.01% of VitalStone Financial's portfolio in Q3 2024, its #347 holding.
847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.